LD-2 disclosure · 2nd Quarter - Report
EBITDA CAPITAL
Coverage · No income or expenses were reported on this filing.
Client
- Name
- EBITDA CAPITAL
- Description
- Work with FDA for treatment approval
- Location
- California · United States of America
Registrant
- Description
- Defence finding
- Location
- Stevensville, Maryland, United States of America
Lobbying activities
1 issueCommunications/Broadcasting/Radio/TV
Inform members of internet technology for rural areas
LobbyistsBILL SARPALIUS
TargetedSENATE · HOUSE OF REPRESENTATIVES
